KINIKSA PHARMACEUTICALS
Kiniksa Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with a significant unmet medical need. It has a pipeline of product candidates across various stages of development, currently focused on autoinflammatory and autoimmune conditions. It has three clinical-stage product candidates, one of which is anticipated to commence a Phase 3 clinical tr... ial in 2018. They follow a disciplined and methodical approach to selectively identify and acquire product candidates with strong biologic rationales or validated mechanisms of action. The company's portfolio of product candidates offers multiple development opportunities. By modulating different parts of the innate and adaptive immune system, these product candidates together have the potential to provide a variety of mechanisms to address multiple devastating diseases.
KINIKSA PHARMACEUTICALS
Industry:
Biopharma Biotechnology Medical
Founded:
2015-01-01
Address:
Hamilton, Hamilton, Bermuda
Country:
Bermuda
Website Url:
http://www.kiniksa.com
Total Employee:
11+
Status:
Active
Contact:
(781) 431-9100
Email Addresses:
[email protected]
Total Funding:
400 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Content Delivery Network Domain Not Resolving Nginx Euro Microsoft Exchange Online
Similar Organizations
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
AxisPharm
AxisPharm specializes in ADC drug development, bioconjugation, mass spectrometry, and structure elucidation.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Stock Details
Investors List
Fidelity
Fidelity investment in Series C - Kiniksa Pharmaceuticals
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Kiniksa Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series C - Kiniksa Pharmaceuticals
Deerfield
Deerfield investment in Series C - Kiniksa Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series C - Kiniksa Pharmaceuticals
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series C - Kiniksa Pharmaceuticals
ArrowMark Partners
ArrowMark Partners investment in Series C - Kiniksa Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series B - Kiniksa Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series A - Kiniksa Pharmaceuticals
Official Site Inspections
http://www.kiniksa.com
- Host name: 151.101.1.193
- IP address: 151.101.1.193
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago